de Vlam, Kurt
Maksymowych, Walter P.
Gallo, Gaia
Rahman, Proton
Mease, Philip
Krishnan, Venkatesh
McVeigh, Conor J.
Lisse, Jeffrey
Zhu, Danting
Bolce, Rebecca J.
Conaghan, Philip G.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 30 January 2024
Accepted: 27 February 2024
First Online: 18 April 2024
Change Date: 14 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40744-024-00686-x
Declarations
:
: Kurt de Vlam has received grant/research support from Celgene and Galapagos; consultancy fees from Celgene, Eli Lilly, Galapagos, Novartis, and UCB; and speaker fees from Celgene, Eli Lilly, Galapagos, Novartis, and UCB. Walter P. Maksymowych is Chief Medical Officer of CARE Arthritis Limited, has acted as a paid consultant/participated in advisory boards for AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer, and UCB; received research and/or educational grants from AbbVie, Novartis, Pfizer, and UCB; and received speaker fees from AbbVie, Janssen, Novartis, Pfizer, and UCB. Proton Rahman has received consulting fees from Abbott, AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, and Pfizer, and has also received research grants from Janssen and Novartis. Philip Mease declares research grants, consultation fees, and/or speaker honoraria from AbbVie, Amgen, Bristol Myers, Boehringer Ingelheim, Galapagos, Gilead, GlaxoSmithKline, Inmagene, Janssen, Lilly, Merck, Novartis, Pfizer, SUN Pharma, and UCB. Philip G. Conagah reports speakers’ bureaus for AbbVie, Eli Lilly, Novartis, and consultancies with AbbVie, Eli Lilly, Genascense, GSK, Galapagos, Grunenthal, Janssen, Levicept, Merck, Moebius, Novartis, Stryker, Takeda, and TrialSpark. Gaia Gallo, Venkatesh Krishnan, Conor J. McVeigh, Jeffrey Lisse, Danting Zhu, and Rebecca J. Bolce are all employees and shareholders of Eli Lilly and Company.
: COAST-V was carried out in accordance with the ethical principles of the Declaration of Helsinki and Good Clinical Practice guidelines. All investigation sites received approval from the appropriate authorized institutional review board or ethics committee. All patients provided written consent before the study-related procedures were carried out. The master ethics committee was Schulman Associates IRB, Cincinnati, OH, USA.